InfuSystem Stock Price, News & Analysis (NYSEAMERICAN:INFU)

$2.30 +0.02 (+0.88 %)
(As of 02/25/2018 03:06 AM ET)
Previous Close$2.30
Today's Range$2.30 - $2.30
52-Week Range$1.20 - $2.45
Volume4,338 shs
Average Volume13,617 shs
Market Capitalization$52.96 million
P/E Ratio-16.43
Dividend YieldN/A
Beta0.12

About InfuSystem (NYSEAMERICAN:INFU)

InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.

Receive INFU News and Ratings via Email

Sign-up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorHealthcare
SymbolNYSEAMERICAN:INFU
CUSIPN/A
Phone+1-248-2911210

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-16.4285714285714
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.14)
Net IncomeN/A
Net Margins-0.73%
Return on Equity-1.06%
Return on Assets-0.59%

Miscellaneous

EmployeesN/A
Outstanding Shares22,780,000

InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

How were InfuSystem's earnings last quarter?

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) issued its quarterly earnings results on Monday, December, 12th. The medical instruments supplier reported $0.00 earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $17.23 million for the quarter. InfuSystem had a negative return on equity of 1.06% and a negative net margin of 0.73%. View InfuSystem's Earnings History.

Who are some of InfuSystem's key competitors?

Who are InfuSystem's key executives?

InfuSystem's management team includes the folowing people:

  • Gregg O. Lehman Ph.D., Executive Chairman of the Board (Age 67)
  • Richard A. Diiorio, President, Chief Executive Officer, Director (Age 43)
  • Christopher Downs, Interim Chief Financial Officer, Executive Vice President (Age 59)
  • Janet Skonieczny, Chief Operating Officer, Executive Vice President, Compliance Officer and Privacy Officer (Age 56)
  • Trent N Smith, Executive Vice President, Chief Accounting Officer, Corporate Controller (Age 48)
  • Michael Milton McReynolds, Executive Vice President, Chief Information Officer (Age 46)
  • Darrell B. Montgomery, Director (Age 55)
  • Ryan J. Morris, Director (Age 32)
  • Christopher R. Sansone, Director
  • Scott A. Shuda, Director (Age 50)

Who owns InfuSystem stock?

InfuSystem's stock is owned by many different of institutional and retail investors. Top institutional shareholders include AWM Investment Company Inc. (6.65%), LSV Asset Management (0.77%) and Renaissance Technologies LLC (0.52%). Company insiders that own InfuSystem stock include Christopher Downs, Christopher R Sansone, Darrell B Montgomery, Eric K Steen, Meridian Ohc Partners, Lp, Richard Dilorio and Ryan J Morris. View Institutional Ownership Trends for InfuSystem.

Who sold InfuSystem stock? Who is selling InfuSystem stock?

InfuSystem's stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management. View Insider Buying and Selling for InfuSystem.

Who bought InfuSystem stock? Who is buying InfuSystem stock?

InfuSystem's stock was purchased by a variety of institutional investors in the last quarter, including AWM Investment Company Inc. and Renaissance Technologies LLC. Company insiders that have bought InfuSystem stock in the last two years include Christopher Downs, Christopher R Sansone, Darrell B Montgomery, Eric K Steen, Meridian Ohc Partners, Lp, Richard Dilorio and Ryan J Morris. View Insider Buying and Selling for InfuSystem.

How do I buy InfuSystem stock?

Shares of InfuSystem can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is InfuSystem's stock price today?

One share of InfuSystem stock can currently be purchased for approximately $2.30.

How big of a company is InfuSystem?

InfuSystem has a market capitalization of $52.96 million.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.


MarketBeat Community Rating for InfuSystem (INFU)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  72
MarketBeat's community ratings are surveys of what our community members think about InfuSystem and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

InfuSystem (NYSEAMERICAN:INFU) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

InfuSystem (NYSEAMERICAN:INFU) Earnings History and Estimates Chart

Earnings by Quarter for InfuSystem (NYSEAMERICAN:INFU)

InfuSystem (NYSEAMERICAN INFU) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2017Q3 2017($0.01)$17.59 millionViewN/AView Earnings Details
8/9/2017Q2 2017($0.02)$16.94 millionViewListenView Earnings Details
5/11/2017Q1 2017($0.06)$17.65 millionViewN/AView Earnings Details
3/22/2017Q4 2016$0.07($0.01)$16.85 millionViewN/AView Earnings Details
12/12/2016Q3 2016$0.00$17.23 millionViewN/AView Earnings Details
8/10/2016Q216$0.04$17.20 million$19.10 millionViewListenView Earnings Details
5/10/2016Q116$0.02$16.70 million$19.00 millionViewN/AView Earnings Details
3/9/2016Q4 2015$0.09$19.54 millionViewN/AView Earnings Details
11/12/2015Q315$0.06$18.69 millionViewListenView Earnings Details
8/13/2015Q2 2015$0.05$17.17 millionViewN/AView Earnings Details
5/12/2015Q115$0.06$0.03$17.20 million$16.70 millionViewListenView Earnings Details
3/9/2015Q414$0.05$0.05$17.20 million$16.20 millionViewN/AView Earnings Details
11/10/2014Q3 2014$0.05$0.04$16.61 millionViewN/AView Earnings Details
8/1/2014Q2 2014$0.04$16.37 millionViewN/AView Earnings Details
5/5/2014Q1 2014$0.03$0.03$17.24 millionViewN/AView Earnings Details
3/11/2014$0.03$0.04$17.18 millionViewN/AView Earnings Details
11/12/2013Q3$0.02$0.03$15.74 millionViewListenView Earnings Details
3/28/2013Q4 2012$0.03ViewN/AView Earnings Details
5/21/2012Q1 2012($0.04)ViewN/AView Earnings Details
3/15/2012Q4 2011$0.01$0.02ViewN/AView Earnings Details
8/11/2011Q2 2011$0.04ViewN/AView Earnings Details
5/12/2011Q1 2011($0.01)ViewN/AView Earnings Details
3/10/2011Q4 2010$0.01($0.11)ViewN/AView Earnings Details
11/10/2010Q3 2010$0.01$0.01ViewN/AView Earnings Details
8/5/2010Q2 2010$0.02$0.01ViewN/AView Earnings Details
3/2/2010Q4 2009$0.05ViewN/AView Earnings Details
11/9/2009Q3 2009$0.01ViewN/AView Earnings Details
8/12/2009Q2 2009$0.04ViewN/AView Earnings Details
5/5/2009Q1 2009($0.14)ViewN/AView Earnings Details
3/5/2009Q4 2008$0.01ViewN/AView Earnings Details
11/5/2008Q3 2008$0.02$0.02ViewN/AView Earnings Details
8/6/2008Q2 2008$0.01$0.01ViewN/AView Earnings Details
3/18/2008Q4 2007($0.01)($0.11)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

InfuSystem (NYSEAMERICAN:INFU) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for InfuSystem (NYSEAMERICAN:INFU)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

InfuSystem (NYSEAMERICAN INFU) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for InfuSystem (NYSEAMERICAN:INFU)
Insider Trades by Quarter for InfuSystem (NYSEAMERICAN:INFU)

InfuSystem (NYSEAMERICAN INFU) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2017Meridian Ohc Partners, LpDirectorBuy64,000$2.32$148,480.00View SEC Filing  
12/8/2017Meridian Ohc Partners, LpDirectorBuy1,800$2.30$4,140.00View SEC Filing  
12/6/2017Meridian Ohc Partners, LpDirectorBuy7,300$2.30$16,790.00View SEC Filing  
11/27/2017Christopher R SansoneDirectorBuy2,000$2.20$4,400.00View SEC Filing  
11/21/2017Christopher R SansoneDirectorBuy54,344$2.09$113,578.96View SEC Filing  
9/11/2017Meridian Ohc Partners, LpDirectorBuy19,982$2.00$39,964.00View SEC Filing  
8/30/2017Meridian Ohc Partners, LpDirectorBuy30,900$1.90$58,710.00View SEC Filing  
8/28/2017Meridian Ohc Partners, LpDirectorBuy30,000$1.90$57,000.00View SEC Filing  
8/25/2017Meridian Ohc Partners, LpDirectorBuy13,381$1.84$24,621.04View SEC Filing  
8/24/2017Meridian Ohc Partners, LpDirectorBuy155$1.80$279.00View SEC Filing  
8/23/2017Meridian Ohc Partners, LpDirectorBuy2,166$1.80$3,898.80View SEC Filing  
8/16/2017Meridian Ohc Partners, LpDirectorBuy56,670$1.84$104,272.80View SEC Filing  
8/15/2017Richard DilorioDirectorBuy4,875$1.95$9,506.2559,659View SEC Filing  
8/14/2017Christopher DownsCFOBuy7,900$1.90$15,010.0028,840View SEC Filing  
8/14/2017Darrell B MontgomeryDirectorBuy25,000$1.88$47,000.0012,000View SEC Filing  
6/7/2017Meridian Ohc Partners, LpDirectorBuy10,109$1.55$15,668.95View SEC Filing  
6/2/2017Meridian Ohc Partners, LpDirectorBuy10,100$1.55$15,655.00View SEC Filing  
5/25/2017Meridian Ohc Partners, LpDirectorBuy6,105$1.55$9,462.75View SEC Filing  
5/19/2017Ryan J MorrisDirectorBuy15,000$1.28$19,200.00View SEC Filing  
5/17/2017Ryan J MorrisDirectorBuy29,614$1.45$42,940.30View SEC Filing  
3/27/2017Ryan J MorrisDirectorBuy21,651$2.20$47,632.20View SEC Filing  
3/24/2017Ryan J MorrisDirectorBuy94,200$2.14$201,588.00View SEC Filing  
12/19/2016Eric K. SteenInsiderBuy12,000$2.33$27,960.00View SEC Filing  
12/16/2016Meridian Ohc Partners, LpDirectorBuy200,000$2.34$468,000.00View SEC Filing  
9/14/2016Ryan J MorrisDirectorBuy23,171$2.85$66,037.35View SEC Filing  
9/13/2016Ryan J MorrisDirectorBuy16,829$2.88$48,467.52View SEC Filing  
9/8/2016Ryan J MorrisDirectorBuy17,171$2.84$48,765.64View SEC Filing  
9/2/2016Ryan J MorrisDirectorBuy4,600$2.84$13,064.00View SEC Filing  
11/19/2015Eric K. SteenCEOBuy2,461$2.88$7,087.68157,217View SEC Filing  
11/12/2015Meridian Ohc Partners, LpMajor ShareholderBuy29,600$2.82$83,472.00View SEC Filing  
11/3/2015Meridian Ohc Partners, LpMajor ShareholderBuy7,689$2.75$21,144.75View SEC Filing  
10/28/2015Meridian Ohc Partners, LpMajor ShareholderBuy17,100$2.71$46,341.00View SEC Filing  
10/13/2015Meridian Ohc Partners, LpMajor ShareholderBuy14,290$2.82$40,297.80View SEC Filing  
10/12/2015Meridian Ohc Partners, LpMajor ShareholderBuy1,860$2.83$5,263.80View SEC Filing  
8/24/2015Eric K. SteenCEOBuy5,000$2.83$14,150.00152,191View SEC Filing  
8/19/2015Eric K. SteenCEOBuy7,360$2.92$21,491.20147,191View SEC Filing  
8/18/2015Jonathan P FosterCFOBuy1,000$2.92$2,920.00View SEC Filing  
6/23/2015Meridian Ohc Partners, LpMajor ShareholderBuy7,500$3.19$23,925.00View SEC Filing  
6/15/2015Gregg Owen LehmanDirectorBuy2,000$3.23$6,460.00View SEC Filing  
6/12/2015Meridian Ohc Partners, LpMajor ShareholderBuy12,786$3.16$40,403.76View SEC Filing  
6/8/2015Gregg Owen LehmanDirectorBuy18,000$3.19$57,420.00View SEC Filing  
6/4/2015David C DreyerDirectorSell10,000$3.15$31,500.00View SEC Filing  
6/4/2015Meridian Ohc Partners, LpMajor ShareholderBuy19,550$3.15$61,582.50View SEC Filing  
5/19/2015Eric K SteenCEOBuy5,682$3.08$17,500.56View SEC Filing  
5/15/2015Jonathan P FosterCFOBuy4,270$3.07$13,108.90View SEC Filing  
12/16/2014Eric K SteenCEOBuy15,100$2.73$41,223.00View SEC Filing  
12/4/2014Eric K SteenCEOBuy3,669$2.65$9,722.85View SEC Filing  
11/26/2014Eric K SteenCEOBuy10,000$2.75$27,500.00View SEC Filing  
11/17/2014Eric K SteenCEOBuy10,000$2.69$26,900.00View SEC Filing  
8/27/2014Eric K SteenCEOBuy15,000$2.75$41,250.00View SEC Filing  
8/18/2014Eric K SteenCEOBuy12,750$2.79$35,572.50View SEC Filing  
8/13/2014Eric K SteenCEOBuy7,262$2.79$20,260.98View SEC Filing  
8/11/2014Eric K SteenCEOBuy11,172$2.71$30,276.12View SEC Filing  
5/7/2014Eric K SteenCEOBuy10,000$2.80$28,000.00View SEC Filing  
3/17/2014Ryan J MorrisChairmanSell24,600$2.90$71,340.00View SEC Filing  
3/13/2014Jonathan P FosterCFOBuy5,000$2.78$13,900.00View SEC Filing  
8/14/2013Eric K SteenCEOBuy15,000$1.42$21,300.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

InfuSystem (NYSEAMERICAN INFU) News Headlines

Source:

SEC Filings

InfuSystem (NYSEAMERICAN:INFU) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

InfuSystem (NYSEAMERICAN:INFU) Income Statement, Balance Sheet and Cash Flow Statement

Chart

InfuSystem (NYSEAMERICAN INFU) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.